Page last updated: 2024-11-13

paracaseolide a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

paracaseolide A: from Chinese mangrove Sonneratia paracaseolaris; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Sonneratiagenus[no description available]LythraceaeThe loosestrife plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. Members are mainly herbs and many of them contain ALKALOIDS.[MeSH]

Cross-References

ID SourceID
PubMed CID122389388
MeSH IDM0569819

Synonyms (22)

Synonym
paracaseolide a
(+/-)-paracaseolide a
paracaseolide a, (-)-
unii-o73zc0u65e
paracaseolide a, (+/-)-
difuro(2,3,4-cd:4',3',2'-hi)isobenzofuran-2,5-dione, 3-dodecyl-2a,3,6a,7a,7b,7c-hexahydro-6a,7a-dimethyl-2a-(1e)-1-tetradecen-1-yl-, (2ar,3s,6as,7ar,7bs,7cr)-rel-
o73zc0u65e ,
1802231-07-7
(-)-paracaseolide a [mi]
1332646-68-0
unii-c74kzc9ayz
1419263-27-6
difuro(2,3,4-cd:4',3',2'-hi)isobenzofuran-2,5-dione, 3-dodecyl-2a,3,6a,7a,7b,7c-hexahydro-6a,7a-dimethyl-2a-(1e)-1-tetradecen-1-yl-, (2ar,3s,6as,7ar,7bs,7cr)-rel-(-)-
unii-774x723r7p
paracaseolide a [mi]
774x723r7p ,
(+)-paracaseolide a
(-)-paracaseolide a
c74kzc9ayz ,
difuro(2,3,4-cd:4',3',2'-hi)isobenzofuran-2,5-dione, 3-dodecyl-2a,3,6a,7a,7b,7c-hexahydro-6a,7a-dimethyl-2a-(1e)-1-tetradecen-1-yl-, (2ar,3s,6as,7ar,7bs,7cr)-rel-(+)-
(+)-paracaseolide a [mi]
paracaseolide a, (+)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]